UNSPSC 51284022: Demeclocycline calcium

This classification denotes a tetracycline antibiotic 2C21H20ClN2O8.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SD6S4YY5HP, chemically known as 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-, calcium salt (2:1), (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, but more generally known as demeclocycline calcium, which bears US NIH Compound Identifier 72941516.

UNSPSC 51284022 Demeclocycline calcium is a Commodity code that nominally identifies a specific tetracycline antibiotic, but recent state and local procurement activity under this code does not align with the product name. The Illinois Department of Public Health's August 2026 piggyback pharmaceutical warehouse order through the MMCAP Infuse consortium awarded $2,999,999.11 to Chartwell Rx LLC for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets — neither of which is demeclocycline calcium. A second opportunity from Seminole County, Florida's June 2026 IFB (due July 26, 2023) sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, also unrelated to the code's nominal scope. State and local procurement offices appear to be tagging unrelated pharmaceutical and health-supply purchases under this code. The issuing bodies identified are a state department (Illinois DPHN) and a county government (Seminole County, Florida).

The code shows minimal relevant recent activity aligned with its product name. Illinois DPHN and Seminole County, Florida are the only recent identified buyers, reflecting activity in two states. No open solicitations matching the actual demeclocycline calcium scope are present in the recent-opportunities block. Business development professionals evaluating this code should verify whether state and local procurement offices are actively buying demeclocycline calcium itself or whether the mislabeling reflects broader taxonomic drift in pharmaceutical procurement coding. The demonstrated activity does not support pursuit based on the code's nominal scope.